EGF-R expression in ductal breast cancer: Proliferation and prognostic implications

Anticancer Research

Volumn 17, Issue 1 B, 1997, Pages 769-774

  Bucci, Barbara ^a,b   D'Agnano, Igea ^b   Botti, Claudio ^a   Mottolese, Marcella ^c   Carico, Elisabetta ^a   Zupi, Gabriella ^a   Vecchione, Aldo ^c,d  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b CNR   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

S; Breast cancer; DNA content; EGF R; Flow cytometry; Prognostic factors

Indexed keywords

DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; STEROID RECEPTOR;

ADULT; AGED; ANEUPLOIDY; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER SURVIVAL; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DNA CONTENT; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PLOIDIES; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 0031048942     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Silvestrini R, Daidone MG, Gasparini G: Cell kinetics as a prognostic marker in node negative breast cancer. Cancer 56: 1982-1987, 1985.
2. Silvestrini R, Daidone MG, Del Bino G, Mastore M, Luisi A, Di Fonzo G, Boracchi P: Prognostic significance activity and ploidy in node-negative breast cancer. Ann Oncol 4: 213-219, 1993.
3. Martelli G, Daidone MG, Mastore M, Gabrielli GM, Galante E, Pilotti S, Silvestrini R: Combined analysis of ploidy and cell kinetics on fine-needle aspirates from breast tumors. Cancer 8: 2522-2527, 1993.
4. Ro J, North SM, Gallick GE, Hortobagyi GN, Gutterman JU, Blick M: Amplified and overexpressed epidermal growth factor receptor gene in uncultured primary human breast carcinoma. Cancer Res 48: 161-164, 1988.
5. Osborne CK, Artega CL: Autocrine and paracrine growth regulation of breast cancer: clinical implications. Breast Cancer Res Treat 15: 3-11, 1990.
6. Lippman ME, Dickson RB, Gelmann EP, Rosen N, Knabbe C, Bates S, Bronzert D, Huff K, Kasid A: Growth regulation of human breast carcinoma occurs through regulated growth factor secretion. J Cell Biol Growth Reg Cancer 35: 1-16, 1987.
7. Colomb E, Berthon P, Dussert C, Calvo F, Martin PI: Estradiol and EGF requirements for cell-cycle progression of normal human mammary epithelial cells in culture. Int J Cancer 49: 932-937, 1991.
8. Harris AL: What is the biological, prognostic, and therapeutic role of the EGF receptor in human breast cancer? Breast Cancer Res Treat 29: 1-2, 1994.
9. Lewis S, Locker A, Todd JH, Bell JA, Nicholson R, Elston CW, Blamey RW, Ellis IO: Expression of epidermal growth factor receptor in breast cancer. J Clin Pathol 43: 385-389, 1990.
10. Spyratos F, Delarue JC, Andrieu C, Lidereau R, Champeme MH, Hacene K, Brunet MP: Epidermal growth factor receptors and prognosis in primary breast cancer. Breast Cancer Res Treat 17: 83-89, 1990.
11. Koenders PG, Beex LVAM, Moespot AG, Heuvel JJTM, CBM, Kienhuis, Bemaad TJ: Epidermal growth factor receptor-negative tumors are predominantly confined to the subgroup of estradiol receptor-positive human primary breast cancer. Cancer Res 51: 4544-4548, 1991.
12. Sainsbury JR, Famdon JR, Needham GK, Malcolm AJ, Harris AL: Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet i: 1398-1402, 1987.
13. Miller DL, Dorraya EI-A, Cheville AL, Liu Y, Mcleskey SW, Kem FG: Emergence of MCF7 cells overexpressing a transfected epidermal growth factor receptor (EGFR) under estrogen-depleted conditions: evidence for a role of EGFR in breast cancer growth and progression. Cell Growth Diff 5: 1263-1274, 1994.
14. Gasparini G, Bevilacqua P, Pozza F, Meli S, Boracchi P, Marubini E, Sainsbury JRC: Value of epidermal growth factor receptor status compared with growth fraction and other factors for prognosis in early breast cancer. Br J Cancer 66: 970-976, 1992.
15. Fitzpatrick SL, LaChance MP, Schultz GS: Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture. Cancer Res 44: 3442-3447, 1984.
16. Peyrat JP, Bonnettere J, Vandewalle B, Djiarre J, Lefebure J: Recepteurs de l'EGF dans les cancers du sein humains. Relations avec les recepteurs hormonaux. Annales Endocr 45: 412-413, 1984.
17. Bevilacqua P, Gasparini G, Dal Fior S, Corradi G: Immunocytochemical determination of epidermal growth factor receptor with monoclonal EGFR1 antibody in primary breast cancer patients. Oncology 47: 313-317, 1990.
18. Koenders PG, Beex LVAM, Kienhuis CBM, Kloppenborg PWC, Benraad ThJ: Epidermal growth factor receptor and prognosis in human breast cancer: a prospective study. Breast Cancer Res Treat 25: 21-27, 1993.
19. Fox SB, Smith K, Hollyer J, Greenall M, Hastrich D, Harris AL: The epidermal growth factor receptor as a prognostic marker: results of 370 patients and review of 3009 patients. Cancer Res Treat 29: 41-49, 1994.
20. Silvestrini R, D'Agnano I, Faranda A, Costa A, Zupi G, Cosimelli M, Quagliolo V, Giannarelli D, Gennari L, Cavaliere R: Flow cytometric analysis of ploidy in colorectal cancer: a multicentric experience. Br J Cancer 67: 1042-1046, 1993.
21. Lampariello F, Sebastiani G, Cordelli E, Spano' M: Modeling fluorescence dispersion in flow cytometric DNA histograms. Cytometry 12: 343-349, 1991.
22. D'Agnano I, D'Angelo C, Savarese A, Carlini M, Garofalo A, Bottari L, Santoro E, Giannarelli D, Vecchione A, Zupi G: DNA ploidy, proliferative index, and epidermal growth factor receptor: expression and prognosis in patients with gastric cancers. Lab Inv 72: 432-438, 1995.
23. Rallet A, Faroux MJ, Theobald SL, Caquot M, Pourny C, Pluot M, Jardillier JC: Epidermal growth factor receptors in breast cancer: Comparison of radioligand and immunocytochemical assays. Anticancer Res 14: 1417-1422, 1994.
24. Gullick WJ: Prevalence of aberrant expression of the epidermal growth factor receptor in human cancer. British Med Bulletin 47: 87-98, 1991.
25. Xu YH, Richert N, Ito S, Merlino GT, Pastan I: Characterization of epidermal growth factor receptor gene expression in malignany and normal human cell lines. Proc Natl Acad Sci USA 81: 7308-7312, 1984.
26. King CR, Kraus MH, Williams LT, Merlino GT, Pastan IH, Aaronson SA: Human tumor cell lines with EGF receptor gene amplification in the absence of abberant sized mRNAs. Nucl Acids Res 13: 8477-8484, 1985.
27. Salomon DS, Zwiebel JA, Bano M, Iosonczy I, Fehnel P, Kidwell WR: Presence of transforming growth factors in human breast cancer cells. Cancer Res 44: 4069-4074, 1984.
28. Lippman ME, Dickson RB, Bates C, Hugg K, Swain S, McMamaway, Bronzert D, Kasid A, Gelmann EP: Autocrine and paracrine growth regulation of human breast cancer. Breast Cancer Res Treat 7: 59-70, 1986.
29. Chrysogelos SA, Dickson RB: EGF receptor expression, regulation, and function in breast cancer. Breast Cancer Res Treat 29: 29-40, 1994.
30. Chrysogelos SA, Yarden RI, Lauber AH, Murphy JM. Mechanism of EGF-R receptor regulation in breast cancer cells. Breast Cancer Res Treat 31: 227-236, 1994.
31. Van Agthoven T, Van Agthoven TLA, Portengen H, Foekens JA, Dorssers LCJ: Ectopic expression of epidermal growth factor receptors induces hormone independence in ZR-75-1 breast cancer cells. Cancer Res 52: 5082-5088, 1992.
32. Pekonen F, Partanen S, Makinen T, Rutanen AM: Receptors for epidermal growth factors and insulin-like growth factor I and their relation to steroid receptors in human breast cancer. Cancer Res 48: 1343-1347, 1988.
33. Toi M, Arihko O, Yamada H, Toge T: Epidermal growth factor receptor expression as a prognostic indicator in breast cancer. Eur J Cancer 27: 977-980, 1991.
34. Macias A, Azavedo E, Hagerstrom T, Klintemberg C, Perez R, Skoog L: Prognostic significance of the receptor for epidermal growth factor in human mammary carcinomas. Anticancer Res 7: 459-464, 1987.